Moreover, LPE18:1 also increased the invasive ability of tumor cells, although it did not alter the expression of EMT-related markers such as N-cadherin, E-cadherin, or ZEB2 (Supplementary Fig. 2e, f). The gene discussed is CDH1; the disease is neoplasm.